Saniona
- Biotech or pharma, therapeutic R&D
Saniona, a clinical stage biopharmaceutical company, is seeking out licensing opportunities for our differentiated preclinical stage epilepsy assets, our novel program for major depression devoid of NMDA- and psychedelic-like adverse effects and our phase 1 ready candidate for rare fibrotic and inflammatory disorders. Read more at http://www.saniona.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}